Ispire Technology vs Zepp Health
Zepp Health is the larger business, with $259m of revenue in fiscal 2025 against $96.0m for Ispire Technology (2.7 times as much). Zepp Health grew faster (41.8% against -24.7%). Zepp Health kept more of each dollar of sales as profit: a net margin of -15.5% against -34.6%.
| Latest fiscal year | Ispire TechnologyISPR, 2026 | Zepp HealthZEPP, 2025 |
|---|---|---|
| Revenue | $96.0m | $259m |
| Revenue growth | -24.7% | 41.8% |
| Net income | −$33.2m | −$40.1m |
| Operating margin | -33.9% | — |
| Net margin | -34.6% | -15.5% |
| Return on equity | — | -17.2% |
| Free cash flow | −$875,368 | −$26.2m |
| Cash | $19.3m | $57.0m |
| Total debt | $0 | $171m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $45,001 | $1.2m |
| Employees | 88 | — |
| Market value | $85.3m | $36.6m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 13 buys, 4 sales | 0 buys, 3 sales |